Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis and Related Disorders
Volume -, Issue -, Pages 105131
Publisher
Elsevier BV
Online
2023-11-07
DOI
10.1016/j.msard.2023.105131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
- (2023) Stephanie Meier et al. JAMA Neurology
- Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
- (2022) Pascal Benkert et al. LANCET NEUROLOGY
- Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial
- (2022) Thomas Williams et al. Multiple Sclerosis Journal
- CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset
- (2020) Francesco Patti et al. ENVIRONMENTAL RESEARCH
- Serum neurofilament light chain
- (2020) Orhan Aktas et al. Neurology-Neuroimmunology & Neuroinflammation
- Renal function is associated with blood neurofilament light chain level in older adults
- (2020) Shoshin Akamine et al. Scientific Reports
- Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
- (2019) Thaleia Kalatha et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY
- Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case–control studies
- (2019) Sarah-Jane Martin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients
- (2019) Diana Ferraro et al. ACTA NEUROLOGICA SCANDINAVICA
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
- (2019) Lorenzo Gaetani et al. Multiple Sclerosis and Related Disorders
- Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS
- (2019) Katja Akgün et al. Neurology-Neuroimmunology & Neuroinflammation
- Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
- (2019) Dejan Jakimovski et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Impaired Neurofilament Integrity and Neuronal Morphology in Different Models of Focal Cerebral Ischemia and Human Stroke Tissue
- (2018) Bianca Mages et al. Frontiers in Cellular Neuroscience
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis
- (2018) Finn Sellebjerg et al. Multiple Sclerosis Journal
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Recommendations for cognitive screening and management in multiple sclerosis care
- (2018) Rosalind Kalb et al. Multiple Sclerosis Journal
- Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
- (2018) Tanuja Chitnis et al. Annals of Clinical and Translational Neurology
- Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2017) Maxim De Schaepdryver et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- Alzheimer disease: Neurofilament light in the blood marks Alzheimer degeneration
- (2017) Ian Fyfe Nature Reviews Neurology
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
- (2016) M.Alba Mañé-Martínez et al. JOURNAL OF NEUROIMMUNOLOGY
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
- (2015) S Modvig et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
- (2014) L. M. Villar et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis
- (2014) C Tortorella et al. Multiple Sclerosis Journal
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
- (2011) J. Kuhle et al. NEUROLOGY
- Characteristics of multiple sclerosis at onset and delay of diagnosis and treatment in Spain (The Novo Study)
- (2010) O. Fernández et al. JOURNAL OF NEUROLOGY
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
- Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
- (2009) C. E. Teunissen et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now